Quad-Cities Investment Group’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Quad-Cities Investment Group's NVS Position: Q2 2026 in Review
Quad-Cities Investment Group reduced its Novartis (NVS) stake by 1.2% in Q2 2026, selling an estimated $4.8K and leaving 2,643 shares worth $414K. The position accounts for 0.15% of the portfolio, ranked #147.
Quad-Cities Investment Group first reported a position in NVS in Q2 2018 and has held it in 24 quarters since. 1,621 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Quad-Cities Investment Group held 2,643 shares of Novartis worth $414K as of Q2 2026.
- Quad-Cities Investment Group sold 32 Novartis shares in Q2 2026, an estimated $4.8K.
- Novartis made up 0.15% of Quad-Cities Investment Group's portfolio in Q2 2026, its #147 holding.
- Quad-Cities Investment Group first reported a position in Novartis in Q2 2018 and has held it in 24 quarters since.
- 1,621 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Quad-Cities Investment Group's 13F filing for Q2 2026, filed 7 Jul 2026.